LPL Financial
IMRX icon

LPL Financial’s Immuneering IMRX Stock Holding History

LPL Financial’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$128K Sell
24,345
-4,780
-16% -$24.5K ﹤0.01% 5619
2025
Q4 		$192K Buy
29,125
+6,725
+30% +$43.2K ﹤0.01% 5459
2025
Q3 		$157K Buy
+22,400
New +$116K ﹤0.01% 5415

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial's IMRX Position: Q1 2026 in Review

LPL Financial reduced its Immuneering (IMRX) stake by 16% in Q1 2026, selling an estimated $24.5K and leaving 24,345 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #5619.

LPL Financial first reported a position in IMRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $192K in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • LPL Financial held 24,345 shares of Immuneering worth $128K as of Q1 2026.
  • LPL Financial sold 4,780 Immuneering shares in Q1 2026, an estimated $24.5K.
  • Immuneering made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5619 holding.
  • LPL Financial first reported a position in Immuneering in Q3 2025 and has held it in 3 quarters since.
  • LPL Financial's Immuneering position peaked at $192K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.